<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04788654</url>
  </required_header>
  <id_info>
    <org_study_id>3-2020-0494</org_study_id>
    <nct_id>NCT04788654</nct_id>
  </id_info>
  <brief_title>Multimodal Analgesia for Cholecystectomy</brief_title>
  <official_title>The Comparison of Multimodal Analgesic Protocols for Laparoscopic Cholecystectomy: Pharmacologic Interventions and Combination of Pharmacologic and Operative Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gangnam Severance Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is important to decrease the postoperative pain in patients undergoing laparoscopic&#xD;
      cholecystectomy. We will compare the pharmacologic analgesia with the parmacologic and&#xD;
      surgical analgesia in patients undergoing laparoscopic cholecystectomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 17, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under curve of postoperative pain for 24 hour</measure>
    <time_frame>At postoperative 24 hour</time_frame>
    <description>Area under curve will be measured using Postoperative pain score at postoperative 24 hour using visual anlogue scale (0: no pain, 10: most imaginable pain).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score,</measure>
    <time_frame>At postoperative 0, 2, 6, and 24 hour</time_frame>
    <description>Postoperative pain score: postoperative pain score will be measured at postoperative 0, 2, 6, and 24 hour using visual anlogue scale (0: no pain, 10: most imaginable pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic requirements,</measure>
    <time_frame>At postoperative 24 hour</time_frame>
    <description>Analgesic requirements will be measured at postoperative 24 hour. Total dose of tramadol, ketorolac, and pethidine will be assessed at postoperative 24 hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>At postoperative 24 hour</time_frame>
    <description>Sleep quality will be measured using sleep quality questionnare at postoperative 24 hour.&#xD;
using sleep quality questionnare.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Laparoscopic Cholecystectomy</condition>
  <arm_group>
    <arm_group_label>Pharmacological group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pharmacological analgesia will be performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pharmacologican and surgical group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pharmacological and surgical analgesia will be performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Celebrex, acetaminophen, and dexamethasone</intervention_name>
    <description>Pharmacological intervention will be performed. Celebrex 200mg, acetaminophen 1g, and dexamethasone 7 mg will be infused perioperatively.</description>
    <arm_group_label>Pharmacological group</arm_group_label>
    <arm_group_label>Pharmacologican and surgical group</arm_group_label>
    <other_name>Pharmacological</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saline irrigation, aspiration of pneumoperitoneum, and low pressure penumoperitoneum</intervention_name>
    <description>Surgical intervention will be performed. Saline irrigation, aspiration of pneumoperitoneum, and low pressure pneumoperitoneum will be performed.</description>
    <arm_group_label>Pharmacologican and surgical group</arm_group_label>
    <other_name>Surgical</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 19 years old or older, with American Society of Anesthesiologists&#xD;
             Physical Status 1-3, and scheduled for elective laparoscopic cholecystectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Recent gastric ulcer disease&#xD;
&#xD;
          2. Hepatic or renal insufficiency&#xD;
&#xD;
          3. Opioid dependency&#xD;
&#xD;
          4. Coagulopathy&#xD;
&#xD;
          5. Pre-existing neurologic or anatomic deficits in the lower extremities&#xD;
&#xD;
          6. Severe psychiatric illness&#xD;
&#xD;
          7. pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Do-hyung Kim</last_name>
    <phone>82-2-2224-3919</phone>
    <email>breadfans@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Do-Hyeong Kim</name>
      <address>
        <city>Seoul</city>
        <zip>seoul</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Do-Hyeong Kim</last_name>
      <phone>82-2-2019-4601</phone>
      <email>gsirb@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gangnam Severance Hospital</investigator_affiliation>
    <investigator_full_name>Do-Hyeong Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>postoperative pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

